|
|
Volumn 4, Issue 5, 2005, Pages 276-277
|
|
Gene variants affect response to antiepileptic drugs.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
CYTOCHROME P 450 CYP2C SUBFAMILY;
CYTOCHROME P-450 CYP2C SUBFAMILY;
CYTOCHROME P450;
NERVE PROTEIN;
PHENYTOIN;
SODIUM CHANNEL;
SODIUM CHANNEL, VOLTAGE GATED, TYPE I, ALPHA PROTEIN;
SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, ALPHA PROTEIN;
ALTERNATIVE RNA SPLICING;
ARTICLE;
DRUG RESISTANCE;
EPILEPSY;
EXON;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
METABOLISM;
ALTERNATIVE SPLICING;
ANTICONVULSANTS;
CARBAMAZEPINE;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG RESISTANCE;
EPILEPSY;
EXONS;
HUMANS;
NERVE TISSUE PROTEINS;
PHENYTOIN;
POLYMORPHISM, GENETIC;
SODIUM CHANNELS;
VARIATION (GENETICS);
|
|
EID: 18944400466
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(05)70066-1 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
